Russell Investments Group’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$74.6K Sell
2025
Q2
$593K Sell
2025
Q1
$2.08M Buy
2024
Q4
$1.6K Buy
2024
Q3
$306 Sell
2024
Q2
$33.6K Buy
2024
Q1
$211 Hold
2023
Q4
$166 Buy
2021
Q3
Sell
2021
Q2
$1.53M Buy